Bioengineering Nanotechnology Initiative (SBIR [R43/R44])

The summary for the Bioengineering Nanotechnology Initiative (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Bioengineering Nanotechnology Initiative (SBIR [R43/R44]): Purpose. Nanotechnology is the understanding and control of matter at dimensions between approximately 1 and 100 nanometers, where unique phenomena enable novel applications. Encompassing nanoscale science, engineering, and technology, nanotechnology involves imaging, measuring, modeling, and manipulating matter at this length scale. The purpose of this trans-NIH Funding Opportunity Announcement (FOA) is to stimulate Small Business Innovation Research (SBIR) grant applications that employ nanotechnology to enable the development of diagnostics and interventions for treating diseases. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-10-149, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Future year amounts will depend on annual appropriations.

Federal Grant Title:	Bioengineering Nanotechnology Initiative (SBIR [R43/R44])
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-10-150
Type of Funding:	Grant
CFDA Numbers:	93.121
CFDA Descriptions:	Oral Diseases and Disorders Research
Current Application Deadline:	May 07, 2013
Original Application Deadline:	May 07, 2013
Posted Date:	Apr 06, 2010
Creation Date:	Apr 06, 2010
Archive Date:	Jun 07, 2013
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Small businesses
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional); • Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028...; • Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Tr...; • HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required); • NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health ...; • Epidemiological and Behavioral Research in Oral Health; • Metagenomic Analyses of the Oral Microbiome; • Phase Iii Clinical Trials in Oral Infectious Diseases
More Grants from the National Institutes of Health: • Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (R...; • Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional); • NIH Research Program Projects (Parent P01 Clinical Trial Optional); • Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R...; • Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028...